5-Years PMCF Study of Ceramic Dental Implants One-piece Versus Two-piece.

Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18+
SponsorCeraRoot SL

About this trial

The goal of this cohort observational study is to compare in the survival rate of ceramic dental implants placed in patients with missing or hopeless teeth . The main question\[s\] it aims to answer are:

* Are there any significant differences in survival rate between the use of one-piece ceramic implant versus the two-piece (TL) variant? * What are the complications associated to the procedure and differences between the two groups.

Eligibility criteria

This trial does not accept healthy volunteers

Qualifiers

Clinical Diagnosis of partial or total edentulism.

Specially indicated for patients with metal allergies and chronic illness due to metal allergies.

Disqualifiers

Local and Systemic contraindications for surgery.

Poor oral hygiene

Patients with health problems, disease or any physical or psychological condition to which an oral surgery may be contraindicated.

Previously irradiated bone

Trial population

The geographic population of study will be the patients in two different private dental centers located in Barcelona (Spain) and Boulder (Colorado, USA).

Trial design

Design model

Cohort

Time perspective

Prospective

Treatments tested in this trial

  • dental implant

    Device

    ceramic dental implant

Treatment groups

652 Participants
are divided into 2 treatment groups
Group A: One-piece1 intervention
Group B: Two-piece (TL)1 intervention

Trial outcomes

Primary outcomes

1

Survival rate

The implant is osseointegrated and in function in the patient's jaw without pain and no mobility.

Time frame
From enrolment to the end of treatment 12 months or more.

Secondary outcomes

1

Complications

Implantitis, mucositis, pain, implant fracture, prosthetic fracture, bone loss,

Time frame
1 year after treatment

Other outcomes

Sponsors and contacts

Click on the lead sponsor to view all of their trials.